News

The Gustave Roussy 2014 annual report is presenting an outline of the achievements, highlights and key figures over the past year.

Compassion, commitment, creativity, dynamism and the sharing of expertise are the values that define Gustave Roussy and lead it to place innovation at the heart of its humanitarian, scientific, technological and...

3 questions to Dr Charles Honoré, head of sarcoma surgery at Gustave Roussy

Co-organised by Gustave Roussy, the 13rd TAT Congress took place in Paris from the 2nd to the 4th of March. Presided over this year by Prof. Jean-Charles Soria, Head of the Drug Development Department (DITEP) at Gustave Roussy, the TAT congress is the first International Meeting on the early development of medicines in oncology. 

In France, childhood cancer affects 1 child in 500. It is the second commonest cause of mortality in those under 15 years of age. The number of patients cured continues to rise and today, 80% are cured of their cancer. At Gustave Roussy, all our professional staff work together every day to make the Child and Adolescent Cancer Department an...